about
Gain-of-function ADCY5 mutations in familial dyskinesia with facial myokymiaAnnotating individual human genomesGenetic relationship between five psychiatric disorders estimated from genome-wide SNPsLongitudinal genome-wide association of cardiovascular disease risk factors in the Bogalusa heart studyLarge-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.Genetic structure of community acquired methicillin-resistant Staphylococcus aureus USA300Accurate detection and genotyping of SNPs utilizing population sequencing dataDigital medicine and the Scripps Translational Science Institute.A covering method for detecting genetic associations between rare variants and common phenotypes.Genotype-based risk and pharmacogenetic sampling in clinical trialsCommon vs. rare allele hypotheses for complex diseasesEffect of direct-to-consumer genomewide profiling to assess disease risk.Meta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with HeightDirect-to-consumer personalized genomic testing.Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Clinical implications of human population differences in genome-wide rates of functional genotypesCharacterization of circulating endothelial cells in acute myocardial infarction.Characteristics of genomic test consumers who spontaneously share results with their health care providerPathway analysis of seven common diseases assessed by genome-wide association.The importance of phase information for human genomics.Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patientsEvaluation of next generation sequencing platforms for population targeted sequencing studies.A common MECP2 haplotype associates with reduced cortical surface area in humans in two independent populations.The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?Genomic information as a behavioral health intervention: can it work?Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial.Association of direct-to-consumer genome-wide disease risk estimates and self-reported disease.Impact of direct-to-consumer genomic testing at long term follow-up.Direct-to-consumer pharmacogenomic testing is associated with increased physician utilisation.Consumer perceptions of direct-to-consumer personalized genomic risk assessments.Influence of genetic polymorphisms on the effect of high- and standard-dose clopidogrel after percutaneous coronary intervention: the GIFT (Genotype Information and Functional Testing) study.Catapulting clopidogrel pharmacogenomics forward.The next phase in human geneticsMeta-analysis of Dense Genecentric Association Studies Reveals Common and Uncommon Variants Associated with HeightGenomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes
P50
Q24293635-E30091CA-DBFD-422D-8AB3-D2A266E51FE8Q26999723-995495DF-4DC5-410F-B0F9-0317512AA8DAQ28296286-39D448AC-26DA-41BE-8B50-D752588D0101Q28943347-B0E3CF00-D77C-4081-AB2F-CD876FCA15AEQ30419436-74BCB3C9-B081-48A8-A26B-9C3D1883C017Q30456251-4AA78881-6398-4C75-95B0-E7C1DE540399Q33530810-EB6042C8-34B7-4E1B-A7E4-8A8F74D6EAF1Q33713395-C0B896C0-500E-4043-81BC-E15A2860FD21Q33728635-43869122-002B-4DCE-852A-A3AFDDD8C2C3Q33941445-C143264E-B436-44D0-8929-391A848A0FF1Q34038820-20DC213E-8306-4DF4-8022-77433483CE93Q34158574-97F9B60F-4C47-49E8-9EDC-9ACCF7194C0BQ34458862-8162646F-C200-41A6-AA82-6D309FA73424Q35230171-ACA5575D-D049-45A1-B05A-44835BCE9EEDQ35844926-4C89DADE-B711-4090-A3F8-3633369DB9B2Q36361047-D2EE5964-B280-42B6-BB01-945CF30E4546Q36660244-B2DA5821-75AB-4D13-A172-444948D034B5Q36920078-A7BF7694-D32C-43DF-BE69-334731EE0BA6Q37014849-06F90510-CF64-4DC4-81F8-2DFB81671D1AQ37120242-07C012EA-1162-42C0-BEAD-7ACE22CA3C30Q37206902-26A407D9-99C5-4D77-A139-7952E1E84593Q37213808-9187D003-9913-44A7-8AFF-EE21920A8917Q37340881-77773B9C-5ED5-47DF-9262-F24DD6FE4165Q37892929-637D682E-D53C-45AE-9A0D-5AB5CC84021DQ37971389-91F029E3-234B-4284-BF8B-AA2CAD5CA124Q38493350-12F99397-26E5-4AC1-9DD9-6754BB9F6C56Q42139226-DB7A3F47-5323-41A6-96CC-E290F002BA1FQ42695084-A321605D-DF63-44A9-BC2B-DD8E62F1A4E4Q45942394-1035A6B7-12FF-46AD-9548-FF99C2230188Q46075798-80A76A9D-990E-46D4-A57E-7DD31D7B8DFDQ46828055-C7870D10-BBD8-40B5-9762-35C06D8C0710Q53461778-B86A8B88-D6ED-4F58-ADFC-FD8CA122A670Q53462071-8CDECBE6-DB4A-45CF-8F69-E20FC3F18F45Q56457854-D304AFE0-7A5D-4895-A931-BAEC1F206B05Q57697186-CCC32B7F-D86C-4266-BDF1-E0C23EB152E4
P50
name
Nicholas J Schork
@ast
Nicholas J Schork
@en
Nicholas J Schork
@nl
type
label
Nicholas J Schork
@ast
Nicholas J Schork
@en
Nicholas J Schork
@nl
prefLabel
Nicholas J Schork
@ast
Nicholas J Schork
@en
Nicholas J Schork
@nl